- Home
- WAVE vs PULM Comparison
WAVE vs PULM Comparison
Compare WAVE & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- PULM
- Stock Information
- Founded
- WAVE 2011
- PULM 2003
- Country
- WAVE Israel
- PULM United States
- Employees
- WAVE N/A
- PULM N/A
- Industry
- WAVE Electric Utilities: Central
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- WAVE Utilities
- PULM Health Care
- Exchange
- WAVE Nasdaq
- PULM Nasdaq
- Market Cap
- WAVE 27.0M
- PULM 33.2M
- IPO Year
- WAVE 2021
- PULM N/A
- Fundamental
- Price
- WAVE $7.10
- PULM $6.21
- Analyst Decision
- WAVE Strong Buy
- PULM
- Analyst Count
- WAVE 1
- PULM 0
- Target Price
- WAVE $15.00
- PULM N/A
- AVG Volume (30 Days)
- WAVE 18.5K
- PULM 55.4K
- Earning Date
- WAVE 08-28-2025
- PULM 08-12-2025
- Dividend Yield
- WAVE N/A
- PULM N/A
- EPS Growth
- WAVE N/A
- PULM N/A
- EPS
- WAVE N/A
- PULM N/A
- Revenue
- WAVE $168,000.00
- PULM $1,921,000.00
- Revenue This Year
- WAVE $325.00
- PULM N/A
- Revenue Next Year
- WAVE $85.71
- PULM $134.88
- P/E Ratio
- WAVE N/A
- PULM N/A
- Revenue Growth
- WAVE N/A
- PULM N/A
- 52 Week Low
- WAVE $2.39
- PULM $1.78
- 52 Week High
- WAVE $17.63
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- WAVE 61.18
- PULM 41.32
- Support Level
- WAVE $6.02
- PULM $6.10
- Resistance Level
- WAVE $6.79
- PULM $6.83
- Average True Range (ATR)
- WAVE 0.35
- PULM 0.33
- MACD
- WAVE 0.06
- PULM -0.05
- Stochastic Oscillator
- WAVE 98.74
- PULM 21.00
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).